Artero Mikel Rezola, Minery Andrea, Nedelcev Leon, Radanova Maria, Roumenina Lubka T
Centre de Recherche des Cordeliers, Institut National de la Santé et de la Recherche Médicale, Sorbonne Université, Université de Paris Cité, Team Inflammation, Complement and Cancer, Paris F-75006, France.
Department of Biochemistry, Molecular Medicine and Nutrigenomics, Medical University of Varna, Varna, Bulgaria.
Semin Immunol. 2025 Jun;78:101950. doi: 10.1016/j.smim.2025.101950. Epub 2025 Apr 2.
The hallmarks of cancer are a set of traits that normal cells acquire during their transformation into malignancy. Among the biological processes influencing these hallmarks, the innate immune complement system plays a critical role. It can operate canonically-in blood and tissues-via phagocytosis, inflammation, and complement-dependent cytotoxicity, similar to its roles against invading pathogens. Additionally, it functions non-canonically by modulating the behavior of cells within the tumor microenvironment and their intracellular landscape which regulates cell fate. These mechanisms contribute to the complex and context-dependent roles of complement in both tumor growth and antitumor immunity, shaped by the characteristics of the dynamic tumor microenvironment. This review analyses the multifaceted interplay between complement proteins and cancer hallmarks, positioning this system as a target to cancer therapy.
癌症的标志是正常细胞在转变为恶性细胞过程中获得的一组特征。在影响这些标志的生物学过程中,先天性免疫补体系统起着关键作用。它可以通过吞噬作用、炎症反应和补体依赖性细胞毒性在血液和组织中以经典方式发挥作用,类似于其对抗入侵病原体的作用。此外,它通过调节肿瘤微环境内细胞的行为及其细胞内环境来发挥非经典功能,从而调节细胞命运。这些机制促成了补体在肿瘤生长和抗肿瘤免疫中复杂且依赖于背景的作用,这是由动态肿瘤微环境的特征所塑造的。本综述分析了补体蛋白与癌症标志之间多方面的相互作用,将该系统定位为癌症治疗的一个靶点。